QA: Moonlake Immunotherapeutics in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001821586_2026_Moonlake_Immunotherapeutics.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001821586, Moonlake Immunotherapeutics

  xvar xval
0 AssetsCurrent 421,694,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 577,000
3 remainder_Assets 2,162,000
4 LiabilitiesCurrent 45,478,000
5 LiabilitiesNoncurrent 74,474,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 43,573,171
9 ResearchAndDevelopmentExpense 387,189,053
10 remainder_Expenses 45,685,387
11 remainder_Revenues 22,611,766
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -847,355
  yvar yval
0 Assets 424,433,000
1 Liabilities 119,952,000
2 Expenses 476,447,611
3 Revenues 22,611,766
4 StockholdersEquity 304,481,000
5 NetIncome -453,835,845
6 ComprehensiveNetIncome -454,259,522
7 BaseVar 522,145,866
8 EconomicCapitalRatiobeforeLimitedLiability 0.770
9 EconomicCapitalRatio 2.11

Edgar->Model Mapping

Feature Distribution

Change over Time